Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1175800.RAQ1pCqmK1nS19kFDQLL80KDqfBKIZKhSAiEi_6m--t40130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1175800.RAQ1pCqmK1nS19kFDQLL80KDqfBKIZKhSAiEi_6m--t40130_assertion type Assertion NP1175800.RAQ1pCqmK1nS19kFDQLL80KDqfBKIZKhSAiEi_6m--t40130_head.
- NP1175800.RAQ1pCqmK1nS19kFDQLL80KDqfBKIZKhSAiEi_6m--t40130_assertion description "[The induction of EMT did not enhance tumour-initiating capacity but, instead, conferred a CD44(+)/CD24(-/low) phenotype as well as cell proliferation, migration, and resistance to doxorubicin and radiation on breast cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1175800.RAQ1pCqmK1nS19kFDQLL80KDqfBKIZKhSAiEi_6m--t40130_provenance.
- NP1175800.RAQ1pCqmK1nS19kFDQLL80KDqfBKIZKhSAiEi_6m--t40130_assertion evidence source_evidence_literature NP1175800.RAQ1pCqmK1nS19kFDQLL80KDqfBKIZKhSAiEi_6m--t40130_provenance.
- NP1175800.RAQ1pCqmK1nS19kFDQLL80KDqfBKIZKhSAiEi_6m--t40130_assertion SIO_000772 24755887 NP1175800.RAQ1pCqmK1nS19kFDQLL80KDqfBKIZKhSAiEi_6m--t40130_provenance.
- NP1175800.RAQ1pCqmK1nS19kFDQLL80KDqfBKIZKhSAiEi_6m--t40130_assertion wasDerivedFrom befree-2016 NP1175800.RAQ1pCqmK1nS19kFDQLL80KDqfBKIZKhSAiEi_6m--t40130_provenance.
- NP1175800.RAQ1pCqmK1nS19kFDQLL80KDqfBKIZKhSAiEi_6m--t40130_assertion wasGeneratedBy ECO_0000203 NP1175800.RAQ1pCqmK1nS19kFDQLL80KDqfBKIZKhSAiEi_6m--t40130_provenance.